98%
921
2 minutes
20
Purpose: To examine the prevalence of epiretinal membrane (ERM) according to the OCT-based severity scales, and to describe associations focusing on the impact of smoking and axial length of the globe.
Design: Cross-sectional study.
Participants: The baseline examination cohort comprised participants from the Tohoku Medical Megabank community cohort recruited from 2013 to 2017.
Methods: In total, 38 118 eyes of 19 486 participants were classified with ERM staging. The characteristics of ERM severity were analyzed, and the association between the prevalence of ERM and ocular and systemic parameters was investigated using logistic regression models. Cubic spline models were constructed to visualize the relationships with lifetime smoking exposure and axial lengths. Regarding ERM severity, the associations between stage 1 and stage 2 or more were analyzed with multivariate analysis.
Main Outcome Measures: Epiretinal membrane prevalence at each stage determined via OCT and factors associated with ERM presence and severity.
Results: The prevalence of ERM was 2.3% per eye (3.6% per person), with a predominance at stage 1. The presence of severe ERM stages was higher in older individuals. The multivariate logistic analysis revealed that older age, female sex, and long axial length were associated with a higher prevalence of ERM. In a multivariate analysis stratified by sex, glaucoma was also identified as a significant factor associated with the prevalence of ERM in women. In the cubic spline model, no consistent trend was observed between smoking and ERM prevalence. However, a U-shaped relationship was indicated between axial length and ERM prevalence. Epiretinal membrane severity highlighted older age, alcohol consumption, and very long axial length as significantly associated compared with stage 1.
Conclusions: Epiretinal membrane prevalence was significantly associated with older age, female sex, and long axial length.
Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12002990 | PMC |
http://dx.doi.org/10.1016/j.xops.2025.100752 | DOI Listing |
Can J Ophthalmol
September 2025
Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, United States. Electronic address:
Objective: To describe observed intraocular pressure (IOP) changes following vitrectomy (PPV) surgery and PPV combined with phacoemulsification in eyes with and without glaucoma.
Methods: A total of 20,894 patients from the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) who underwent vitrectomy surgery for epiretinal membrane or vitreous opacities from January 2016 to March 2023 were included. Mean IOPs from postoperative day 1, days 2-10, days 11-30, and then monthly through 6 months were compared to baseline.
Ophthalmol Glaucoma
September 2025
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, England; Discipline of Clinical Ophthalmology and Eye Health, University of Sydney, Sydney, New South Wales, Australia.
Purpose: To compare the long-term safety of MicroShunt implantation with trabeculectomy in eyes with primary open-angle glaucoma (POAG).
Methods: This was a 3-year observational extension of a 2-year prospective randomized trial comparing clinical outcomes of MicroShunt implantation with trabeculectomy, both augmented with mitomycin C. Adverse events (AEs), intraocular pressure (IOP), and IOP-lowering medication use were recorded 36, 48, and 60 months after initial randomization.
BMJ Case Rep
September 2025
Manchester Royal Eye Hospital, Manchester, UK.
We report a case of a young woman who presented with a vitreous haemorrhage associated with a combined hamartoma of the retina and retinal pigment epithelium (CHRRPE). During her clinical course, while the vitreous haemorrhage resolved, the lesion enlarged with a worsening epiretinal membrane. The patient's visual acuity reduced from 0.
View Article and Find Full Text PDFRetina
August 2025
Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Purpose: To investigate the rate and progression of epiretinal membrane (ERM) formation following scleral buckling (SB) for rhegmatogenous retinal detachment (RRD).
Methods: A retrospective review of eyes undergoing SB for RRD repair between January 2015 and June 2022 that developed ERM. ERM grading and structural analysis were performed using spectral domain optical coherence tomography (SD-OCT) based on a standardized scheme.
PLoS One
September 2025
Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
The epiretinal membrane (ERM) is a fibrocellular layer that forms on the inner surface of the retina, often leading to visual impairment and significantly impacting visual function. Understanding the pathophysiology of ERM formation is crucial for advancing ophthalmic care and improving patient outcomes. This research aims to investigate the pathophysiology of ERM by comparing the internal limiting membrane (ILM) pathology in patients with and without ERM.
View Article and Find Full Text PDF